MIRA INFORM REPORT
|
Report Date : |
01.11.2014 |
IDENTIFICATION DETAILS
|
Name : |
RELIANCE LIFE
SCIENCES PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Dhirubhai Ambani Life Sciences Centre, R-282, TTC Area of MIDC, Thane
Belapur Road, Rabale, Navi Mumbai – 400 701, Maharashtra |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2013 |
|
|
|
|
Date of
Incorporation : |
30.01.2001 |
|
|
|
|
Com. Reg. No.: |
11-130654 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.293.850 Millions |
|
|
|
|
CIN No.: [Company Identification No.] |
U24239MH2001PTC130654 |
|
|
|
|
TIN No.: |
27830130587 |
|
|
|
|
TAN No.: [Tax Deduction & Collection Account No.] |
MUMR10629D |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AABCR7594L |
|
|
|
|
Legal Form : |
Private Limited
Liability Company |
|
|
|
|
Line of
Business : |
Subject is involved
in domains such as biopharmaceuticals (plasma proteins, bio-similars, novel
proteins), pharmaceuticals (active pharmaceutical intermediates (APIs),
formulations, drug discovery), clinical research services, regenerative
medicine (stem cell therapies, tissue engineered products, etc.), molecular
medicine (DNA-based diagnostics, molecular genetics, predictive diagnostics),
novel therapeutics (RNA molecules), R & D activities, plant tissue
culture, plant metabolic engineering and industrial biotechnology
(biopolymers, bio-chemicals). |
|
|
|
|
No. of Employees
: |
Information declined by the management |
RATING & COMMENTS
|
MIRA’s Rating : |
A (62) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Maximum Credit Limit : |
USD 3000000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a part of Reliance Group. It is a well-established company
having fine track record. The company has taken huge external borrowing, which acts as threatening
to the liquidity position of the company. However, the rating takes into consideration company’s improved
operations during 2013 and good financial and managerial support that company
from its Reliance Group. Trade relations are reported as fair. Business is active. Payments are
reported to be regular and as per commitment. The company can be considered good for normal business dealings at
usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 1, 2014
|
Country Name |
Previous Rating (31.03.2014) |
Current Rating (01.06.2014) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INDIAN ECONOMIC OVERVIEW
N E W S
Verdict Implications
: Apex court order may alter coal import dynamics. Traders go slow on talks
over coal supply contracts, uncertainty over cancellation of blocks weigh on
stocks.
Recent arrest of the
Chennai head of the Registrar of Companies, the ministry of corporate affairs
arm that ensures that companies file all the information required by the
Companies Act is the latest manifestation of a messy fight between a father and
his adopted son for the control of Rs 40000 mn business empire. The Central
Bureau of Investigation arrested Manumeethi Cholan after he accepted Rs 10
lakhs as bribe from M A M Ramaswamy, a CBI official said.
Central Bureau of
Investigation books Electrotherm for cheating Central Bank of Rs 4360 mn.
Infosys maintains
revenue guidance. COO Rao says attrition still an area of concern and it would
take a few more quarters to bring down levels to 13-15 %.
DHL to invest
Euro 100 mn in India over next 2 years. The firm has chosen India to pilot its
e-commerce business model for the Asia-Pacific region.
Blackstone may buy
stake in BlueRidge SEZ in line with the fund’s real estate strategy in India.
Kingfisher Airlines
Ltd grounded in October 2012 under the weight of heavy debt and accumulated
losses, recently approached the Delhi high court for relief in two separate
cases. The airline challenged a notice by Punjab & National Bank alleging
that It had wilfully defaulted on Rs 7700 mn of loans and sought more time to
comply with the requirements under the listing agreements with the Stock
Exchanges.
OnMobile likely to
sack another 300 employees. The lay-offs follow a spate of senior-level exits
over the past two years, starting with of its founder. The overall lay-offs
could number around 600 and are driven by the need to cut costs, says a former
employee.
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CARE |
|
Rating |
AA
(Long Term Bank Facilities ) |
|
Rating Explanation |
High degree of safety and very low credit
risk |
|
Date |
December 02, 2013 |
|
Rating Agency Name |
CARE |
|
Rating |
A1+ (Short Term Bank Facilities) |
|
Rating Explanation |
Very strong degree of safety and lowest
credit risk |
|
Date |
December 02, 2013 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2014.
INFORMATION DECLINED BY
|
Name : |
Mr. Ravi |
|
Designation : |
Marketing Department |
|
Contact No.: |
91-22-67678134 |
|
Date : |
30.10.2014 |
LOCATIONS
|
Registered Office : |
Dhirubhai Ambani Life Sciences Centre, R-282, TTC Area of MIDC, Thane
Belapur Road, Rabale, Navi Mumbai – 400 701, Maharashtra, India |
|
Tel. No.: |
91-22-67678000/
39118000 |
|
Fax No.: |
91-22-67678099/
39118099 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Corporate
Office : |
3rd Floor Sadhana House, Behind Mahindra Towers, 570, Pandurang Bhudkar Marg Worli, Mumbai – 400 018, Maharashtra, India
|
|
|
|
|
Factory : |
1st Floor, Sadhana Mills Premises, 570,
Pandurang Budhkar Marg, Mumbai - 400 018, Maharashtra, India |
|
|
|
|
Branch Office
: |
Located
at:
|
DIRECTORS
As on 30.09.2013
|
Name : |
Mr. Rahul Ramesh Padhye |
|
Designation : |
Whole Time Director |
|
Address : |
Flat No. 31, 3rd Floor, A Wing, Indrayani Complex, J.K. Sawant
Marg, Dadar (West), Mumbai – 400028, Maharashtra, India |
|
Date of Birth/Age : |
29.06.1972 |
|
Date of Appointment : |
30.09.2013 |
|
DIN No.: |
01555700 |
|
|
|
|
Name : |
Mr. Laxmidas Vallabhdas Merchant |
|
Designation : |
Director |
|
Address : |
Ramkrupa Tower, 9th Floor Block Nbo 12, Dr. Parekh Street,
Prathana Samaj, Mumbai – 400 004, Maharashtra, India |
|
Date of Birth/Age : |
14.11.1959 |
|
Qualification : |
B. Com., Chartered Accountant |
|
Date of Appointment : |
29.09.2007 |
|
DIN No.: |
00007722 |
|
|
|
|
Name : |
Mr. Dinesh Bhaskar Sathe |
|
Designation : |
Whole Time Director |
|
Address : |
A2-601, Rutu Park CHS., RW Sawant Marg, Majiwada, Thane – 400 601,
Maharashtra, India |
|
Date of Birth/Age : |
04.10.1956 |
|
Qualification : |
B.E.(MECH), DMS |
|
Date of Appointment : |
30.09.2010 |
|
PAN No.: |
AERPS8523B |
|
DIN No.: |
02876683 |
KEY EXECUTIVES
|
Name : |
Mr. Hardeep Singh Sodhi |
|
Designation : |
Secretary |
|
Address : |
D – 1/8 – 6, Millenium Towers, Sector – 9, Sanpada, Navi Mumbai –
400705, Maharashtra, India |
|
Date of Birth/Age : |
14.08.1966 |
|
Date of Appointment : |
01.02.2013 |
|
PAN No.: |
ABHPS7806G |
|
|
|
|
Name : |
Mr. Ravi |
|
Designation : |
Marketing Department |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 30.09.2013
|
Names of Shareholders (Equity Shares) |
No. of Shares |
|
Reliance Health
and Technology Private Limited, India |
1700 |
|
Healthcare Systems
and Solution Global Private Limited, India
|
1600 |
|
Reliance Agrotech
Private Limited, India |
1000 |
|
Ekansha Enterprise Private Limited, India |
1700 |
|
Reliance Research and Development Services Private Limited, Mumbai |
1700 |
|
Reliance Qualnet.com Private Limited, Mumbai |
1300 |
|
Reliance Web Spiders.com Private Limited, Mumbai |
1000 |
|
Total
|
10000 |
|
Names of Shareholders (9% Optionally Convertible Non-cumulative
Redeemable Preference Shares) |
No. of Shares |
|
Reliance Ports
and Terminals Limited, India |
8125000 |
|
Total
|
8125000 |
|
Names of Shareholders (10% Non-Convertible Non-cumulative Redeemable
Preference Shares : Series - II) |
No. of Shares |
|
Reliance Ports
and Terminals Limited, India |
1500000 |
|
Total
|
1500000 |
|
Names of Shareholders (9% Optionally Convertible Non-cumulative
Redeemable |
No. of Shares |
|
Reliance Ports
and Terminals Limited, India |
19750000 |
|
Total
|
19750000 |
AS ON 30.09.2013
|
Equity Share Breakup |
|
Percentage of Holding |
|
Category |
|
|
|
Bodies
corporate |
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Subject is
involved in domains such as biopharmaceuticals (plasma proteins, bio-similars,
novel proteins), pharmaceuticals (active pharmaceutical intermediates (APIs),
formulations, drug discovery), clinical research services, regenerative
medicine (stem cell therapies, tissue engineered products, etc.), molecular
medicine (DNA-based diagnostics, molecular genetics, predictive diagnostics),
novel therapeutics (RNA molecules), R & D activities, plant tissue
culture, plant metabolic engineering and industrial biotechnology
(biopolymers, bio-chemicals). |
||||||||
|
|
|
||||||||
|
Products : |
|
GENERAL INFORMATION
|
No. of Employees : |
Information declined by the management |
|||||||||||||||||||||
|
|
|
|||||||||||||||||||||
|
Bankers : |
·
Canara Bank, Prime Corporate Branch II, 2nd
Floor, Varma Chambers, Homji Street, Fort, Mumbai – 400 001, Maharashtra,
India |
|||||||||||||||||||||
|
|
|
|||||||||||||||||||||
|
Facilities : |
(Rs.
In Millions)
Loans From
Department of Biotechnology: (A)The secured
loans taken from Department of Biotechnology (DBT) is secured by hypothecation
of the whole of movable properties of the Company created under the
respective projects and acquired from the respective loan sanctioned by the
DBT including movable plant and machinery, machinery spares, tools and
accessories and other movables both present and future (save and except book
debts) for the said projects. Term Loans from
Department of Biotechnology (DBT) are payable in ten equal annual
installments and will commence after six months of the scheduled completion
of the project. (A) Secured Working capital loan from bank is secured by hypothecation
of stocks and book debts of the Company. |
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Chaturvedi and Shah Chartered Accountants |
|
Address : |
714-715, Tulsiani Chambers, Nariman Point, Mumbai – 400 021,
Maharashtra, India |
|
Tel. No.: |
91-22-56308508 |
|
PAN No.: |
AAAFC0662N |
|
|
|
|
Associates : |
CIN No.: U85199MH2000PTC126806
CIN No.: U85199MH2000PTC126387
CIN No.: U01110GJ1994PTC021440
CIN No.: U15300MH1999PTC123316 |
|
|
|
|
Subsidiaries : |
|
CAPITAL STRUCTURE
As on 30.09.2013
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
510000 |
Equity Shares |
Rs.10/- each |
Rs.5.100 Millions |
|
29500000 |
Preference
Shares |
Rs.10/- each |
Rs.295.000 Millions |
|
|
Total
|
|
Rs.300.100
Millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
10000 |
Equity Shares |
Rs.10/- each |
Rs. 0.100 Million |
|
29375000 |
Preference
Shares |
Rs.10/- each |
Rs. 293.750 Millions |
|
|
Total
|
|
Rs.293.850
Millions |
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
293.850 |
96.350 |
96.350 |
|
(b) Reserves & Surplus |
786.099 |
613.993 |
698.122 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending
allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
1079.949 |
710.343 |
794.472 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
5540.822 |
5597.922 |
5546.278 |
|
(b) Deferred tax liabilities (Net) |
0.000 |
0.000 |
0.000 |
|
(c) Other long term
liabilities |
3.466 |
0.368 |
0.000 |
|
(d) long-term
provisions |
0.000 |
0.000 |
0.000 |
|
Total Non-current
Liabilities (3) |
5544.288 |
5598.290 |
5546.278 |
|
|
|
|
|
|
(4)
Current Liabilities |
|
|
|
|
(a) Short
term borrowings |
806.059 |
897.987 |
541.502 |
|
(b) Trade
payables |
1036.444 |
661.110 |
672.843 |
|
(c) Other
current liabilities |
187.383 |
192.043 |
303.220 |
|
(d) Short-term
provisions |
38.163 |
20.442 |
42.824 |
|
Total Current
Liabilities (4) |
2068.049 |
1771.582 |
1560.389 |
|
|
|
|
|
|
TOTAL |
8692.286 |
8080.215 |
7901.139 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1)
Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i)
Tangible assets |
2444.656 |
2184.239 |
2036.182 |
|
(ii) Intangible
Assets |
142.277 |
228.409 |
70.732 |
|
(iii)
Capital work-in-progress |
144.410 |
434.310 |
582.235 |
|
(iv)
Intangible assets under development |
188.795 |
98.233 |
140.552 |
|
(b) Non-current Investments |
2181.905 |
2181.905 |
2181.186 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
1102.630 |
952.281 |
712.860 |
|
(e) Other
Non-current assets |
172.613 |
104.679 |
48.642 |
|
Total Non-Current
Assets |
6377.286 |
6184.056 |
5772.389 |
|
|
|
|
|
|
(2)
Current assets |
|
|
|
|
(a)
Current investments |
0.000 |
0.000 |
0.000 |
|
(b)
Inventories |
1272.009 |
737.521 |
758.767 |
|
(c) Trade
receivables |
743.150 |
814.958 |
987.991 |
|
(d) Cash and
cash equivalents |
44.151 |
50.296 |
49.735 |
|
(e)
Short-term loans and advances |
255.690 |
292.719 |
332.257 |
|
(f) Other
current assets |
0.000 |
0.665 |
0.000 |
|
Total
Current Assets |
2315.000 |
1896.159 |
2128.750 |
|
|
|
|
|
|
TOTAL |
8692.286 |
8080.215 |
7901.139 |
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
|
|
SALES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Income |
|
|
|
|
|
|
TOTAL (A) |
4334.700 |
3338.100 |
2840.000 |
|
|
|
|
|
|
|
|
Less |
|
|
|
|
|
|
|
|
Office Expenses |
|
|
|
|
|
|
Administrative Expenses |
|
|
|
|
|
|
Advertising Expenses |
|
|
|
|
|
|
TOTAL (B) |
3928.137 |
3145.098 |
2694.992 |
|
|
|
|
|
|
|
|
Less |
PROFIT
/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
406.563 |
193.002 |
145.008 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
96.716 |
99.039 |
42.500 |
|
|
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
310.147 |
93.963 |
102.508 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
216.238 |
179.012 |
108.182 |
|
|
|
|
|
|
|
|
|
|
PROFIT / (LOSS)
BEFORE TAX (E-F) (G) |
93.909 |
(85.049) |
(5.674) |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
|
|
PROFIT / (LOSS)
AFTER TAX (G-H) (I) |
93.909 |
(85.049) |
(5.674) |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
1307.545 |
1315.955 |
793.069 |
|
|
|
|
|
|
|
|
|
|
Earnings /
(Loss) Per Share (Rs.) |
9390.90 |
(8504.90) |
(567.40) |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
Return on Total Assets (PBT/Total Assets} |
(%) |
1.52
|
(1.59)
|
(0.11)
|
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.08
|
(0.12)
|
(0.01)
|
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt /Networth) |
|
5.87
|
9.14
|
7.66
|
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.19
|
3.38
|
2.84
|
FINANCIAL ANALYSIS
[all figures are
in Rupees Millions]
DEBT EQUITY RATIO
|
Particular |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(Rs. In Millions) |
(Rs. In Millions) |
(Rs. In Millions) |
|
Share Capital |
96.350 |
96.350 |
293.850 |
|
Reserves & Surplus |
698.122 |
613.993 |
786.099 |
|
Net worth |
794.472 |
710.343 |
1079.949 |
|
|
|
|
|
|
long-term borrowings |
5546.278 |
5597.922 |
5540.822 |
|
Short term borrowings |
541.502 |
897.987 |
806.059 |
|
Total borrowings |
6087.780 |
6495.909 |
6346.881 |
|
Debt/Equity ratio |
7.663 |
9.145 |
5.877 |
YEAR-ON-YEAR GROWTH
|
Year on Year Growth |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(Rs. In Millions) |
(Rs. In Millions) |
(Rs. In Millions) |
|
Sales |
2840.000 |
3338.100 |
4334.700 |
|
|
|
17.539 |
29.855 |
NET PROFIT MARGIN
|
Net Profit Margin |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(Rs. In Millions) |
(Rs. In Millions) |
(Rs. In Millions) |
|
Sales |
2840.000 |
3338.100 |
4334.700 |
|
Profit |
(5.674) |
(85.049) |
93.609 |
|
|
(0.20%) |
(2.55%) |
2.16% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info
Agents |
Available in Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
No |
|
9] |
Name of person contacted |
Yes |
|
10] |
Designation of contact person |
Yes |
|
11] |
Turnover of firm for last three years |
Yes |
|
12] |
Profitability for last three years |
Yes |
|
13] |
Reasons for variation <> 20% |
---------------------- |
|
14] |
Estimation for coming financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister concerns |
Yes |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details (if applicable) |
No |
|
21] |
Market information |
---------------------- |
|
22] |
Litigations that the firm / promoter involved in |
---------------------- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking account |
---------------------- |
|
26] |
Buyer visit details |
---------------------- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if applicable |
Yes |
|
29] |
Last accounts filed at ROC |
Yes |
|
30] |
Major Shareholders, if available |
Yes |
|
31] |
Date of Birth of Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of Proprietor/Partner/Director, if available |
No |
|
33] |
Voter ID No of Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating, if available |
Yes |
Note:
The registered office of the company has been shifted from 2nd Floor, Chitrakoot, shree Ram
Mills Premises, Ganpatrao Kadam Marg, Worli, Mumbai – 400 013, Maharashtra,
India to the present address w.e.f. 05.04.2007.
UNSECURED LOANS
|
Particulars |
31.03.2013 (Rs.
in Millions) |
31.03.2012 (Rs.
in Millions) |
|
LONG-TERM BORROWINGS |
|
|
|
Rupee term loans from others |
2.059 |
2.059 |
|
Inter corporate borrowings |
5528.169 |
5585.269 |
|
|
|
|
|
LONG-TERM BORROWINGS |
|
|
|
Working Capital Loans From Banks (Unsecured) |
805.879 |
0.000 |
|
Total
|
6336.107 |
5587.328 |
Loans from
Department of Biotechnology (DBT)
Term Loans from Department
of Biotechnology (DBT) are payable in ten equal annual installments and will
commence after six months of the scheduled completion of the project.
(A)Zero Coupon
Optionally Convertible Loan from bodies corporate are convertible into equity
shares of the Company at fair value to be determined at the time of conversion
and if not opted for conversion ,shall be repayable on completion of 20 years
from the date of first disbursement or such period as maybe mutually agreed.
OPERATIONAL AND
FINANCIAL REVIEW:
During the year,
total revenue from sales and services were at Rs. 4334.700 Millions as compared
to Rs.3338.100 Millions for 2011-12.
Export earnings
for the year were recorded at Rs. 1707.000 Millions as against Rs. 1263.900
Millions for 2011-12. During the year, Company has launched multiple products
in different therapy areas. Pedialb TM – Human Norma lAlbumin 5% solution,
recommended in children for indications like hypovolaemic shock,
hypoproteinemia and burns. Relist at TM –Hemostatic kit containing human
thrombin, indicated as a haemostatic device for surgical procedures.In the
international markets, Company has made further progress in terms of product
registrations (recombinant biosimilars).
INDEX OF CHARGES
|
S.No. |
Charge ID |
Date of Charge
Creation/Modification |
Charge amount
secured |
Charge Holder |
Address |
Service Request
Number (SRN) |
|
1 |
10474311 |
30/01/2014 |
1,000,000,000.00 |
AXIS BANK
LIMITED |
AXIS HOUSE, GROUND
FLOOR,, WADIA INTERNATIONAL CENTRE, WORLI, MUMBAI, MAHARASHTRA - 400025,
INDIA |
B94977089 |
|
2 |
10258255 |
19/11/2010 |
12,650,000.00 |
DEPARTMENT OF
BIOTECHNOLOGY |
BLOCK 2, CGO
COMPLEX, LODHI ROAD,, NEW DELHI, DELHI - 110003, INDIA |
B00571265 |
|
3 |
10257683 |
19/11/2010 |
3,900,000.00 |
DEPARTMENT OF
BIOTECHNOLOGY |
BLOCK 2, CGO
COMPLEX, LODHI ROAD,, NEW DELHI, DELHI - 110003, INDIA |
B00498733 |
|
4 |
10115694 |
10/09/2013 * |
1,850,000,000.00 |
CANARA BANK |
PRIME CORPORATE BRANCH-II,2ND
FLOOR,, VARMA CHAMBERS, HOMJI STREET, FORT, MUMBAI, MAHARASHTRA - 400001,
INDIA |
B86067923 |
* Date of charge modification
FIXED ASSETS
Tangible
assets
- Leasehold land
- Buildings
- Plant and machinery
- Data processing equipment
- Vehicles
- Furniture and fixture
Intangible
assets
- Patents, trade
- Marks, designs, etc
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or anti-terrorism
sanction laws or whose assets were seized, blocked, frozen or ordered forfeited
for violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.61.41 |
|
|
1 |
Rs.98.06 |
|
Euro |
1 |
Rs.77.19 |
INFORMATION DETAILS
|
Information
Gathered by : |
DPA |
|
|
|
|
Analysis Done by
: |
KAR |
|
|
|
|
Report Prepared
by : |
NTH |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
7 |
|
PAID-UP CAPITAL |
1~10 |
7 |
|
OPERATING SCALE |
1~10 |
7 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
7 |
|
--PROFITABILIRY |
1~10 |
7 |
|
--LIQUIDITY |
1~10 |
7 |
|
--LEVERAGE |
1~10 |
7 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
7 |
|
--MARGINS |
-5~5 |
--- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
62 |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.